DHSS invites you to join us in a virtual session on Test-to-Treat options.  We will go over the latest information about COVID-19 therapeutics, testing, and vaccines.  

Who: Clinicians, Public Health, Community Leaders, Hospitals, Pharmacists, Tribal Health Partners, Emergency Managers, EMS, and more!
What: A virtual informational and Q&A session for Test-to-Treat in Alaska and other COVID-19 updates
When: See  flyer  
Where: See flyer for your regions link 
Why: Our goal is to offer resources on COVID-19 therapeutics at the community level, and to share and understand local challenges, barriers, resources, and ultimately strengthen partnerships.

We will go over:  

• Detailed overview of current COVID-19 therapeutics options 
• Who is considered high-risk, and who is eligible for outpatient treatment 
• Who is eligible for pre-exposure prophylaxis (Evusheld) 
• Prescribing information and clinical considerations for treatments 
• Barriers to increasing access to therapeutics, and strategies to overcome them 
• The latest vaccine information 
• The latest testing information 
• Tools for the community and for clinicians 

Before the session, please take a moment to look over the following: 

1. Are you familiar with the EUAs and prescribing information for COVID-19 therapeutics?   

• Paxlovid EUA 
• Molnupiravir EUA  
• Bebtelovimab EUA  
• Remdesivir Prescribing Information  
• Evusheld EUA 

1. Are the treatment site locator maps for your community accurate? Please review:  

• Therapeutics Locator  
• Test to Treat Locator  

1. How is access to testing in your community?  Will that change in the coming months?  
2. Is the public aware of treatment options, and what strategies would be most effective in your community to increase public awareness?

For more information on COVID therapeutics, visit http://covidrx.alaska.gov